Evaluation of Remin Pro Forte Versus Remin Pro on Treatment of White Spot Lesions Post Orthodontic Treatment
Launched by CAIRO UNIVERSITY · Jul 11, 2019
Trial Information
Current as of August 11, 2025
Unknown status
Keywords
ClinConnect Summary
Recently, a remineralizing water based cream containing Hydroxyapatite, Fluoride and Xylitol (Remin pro) has been introduced. It has been claimed that hydroxyapatite fills eroded enamel, fluoride seals dentinal tubules and xylitol acts as an antibacterial agents. This product has been assumed to be suitable for management of dentinal hypersensitivity, prevention of enamel demineralization and promoting remineralization of enamel subsurface lesions. There are few studies regarding the effect of calcium phosphate and hydroxyapatite-based agents on remineralization and optical appearance of Wh...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. No systemic disease.
- • 2. Has completed fixed orthodontic treatment, brackets debonded.
- • 3. Has at least two teeth with white spot lesion.
- • 4. Has received conventional periodontal therapy after orthodontic treatment.
- • 5. Between the ages of 12 and 25 years of age.
- Exclusion Criteria:
- • 1. Presence of enamel hypoplasia or dental fluorosis.
- • 2. Presence of tetracycline pigmentation.
- • 3. Periodontal pocketing of 3mm or greater.
- • 4. Taking antibiotics.
- • 5. Presence of carious cavities.
- • 6. Allergy to fluoride gel / varnish being used in study.
- • 7. Subjects who had evidence of reduced salivary flow or significant tooth wear
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
mennatallah aboulnaga, MD
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials